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Summary In an analysis of mutations in the RB1 gene in three patients, selected at random, who had a
positive family history of tumours, we identified mutations, in constitutional cells, involving exons 3, 13 and 17
of the RB1 gene. We used SSCP and PCR sequencing to screen affected individuals and other members of
their families. In two cases the mutations were 2 bp and I bp deletions identified in exons 3 and 17
respectively. The third mutation was a 1 bp insertion in exon 13. All three mutations lead to the generation of
downstream premature stop codons as a result of frameshift changes, although the mutation in exon 3
possibly affects the splicing mechanism. The sites within the RBI gene where these mutations occur contain
interspersed repetitive DNA sequences, direct and inverted repeat sequences and/or dyad symmetrical elements
suggesting that these areas promote the appropriate local sequence environment for the generation of deletions
and insertions in the RB1 gene.
Retinoblastoma (Rb) is an intraocular eye tumour of child-
ren with an incidence of 1 in 15000-25000 and has both
hereditary and sporadic forms (Cowell & Hogg, 1992; Vogel,
1979). The gene responsible, RBI, is one of the class of
'recessive cancer genes', both copies of which must be inac-
tivated for tumorigenesis to occur (Cavenee et al., 1985;
Knudson, 1971). In hereditary cases, the first inactivating
mutation is present constitutionally in predisposed individ-
uals and, when the second mutation occurs in a retinal
precursor cell, tumour initiation results. In non-hereditary
cases, both mutations occur in retinal precursor cells. In a
postulated 70% of tumours homozygous loss of function of
RB1 results from the duplication of the initial mutation
(Cavenee et al., 1983; Zhu et al., 1992). In the remaining
cases homozygous inactivation of RB1 apparently results
from two independent mutations. Approximately 15% of Rb
patients have a positive family history and carry 'old' germ-
line mutations although, since bilateral cases are generally
considered to be carriers of a germ-line predisposing muta-
tion (Knudson, 1971), an additional 25-35% carry 'new'
germ-line mutations (Draper et al., 1992).
Following the molecular cloning of RBI (Friend et al.,
1986) and identification of polymorphic restriction enzyme
sites (Wiggs et al., 1988) genetic screening using linkage
analysis became available for familial cases of Rb (Goddard
et al., 1990; Onadim et al., 1992a; Onadim et al., 1990;
Scheffer et al., 1989; Wiggs et al., 1988). This form of genetic
screening, however, is not available for individuals carrying
'new' germ-line mutations. For unequivocal identification of
these cases it was necessary to identify the causative muta-
tions. This procedure has proved difficult in the past because
of non-availability of fast and reliable mutation-screening
techniques. In recent years, however, many such techniques
have become available, although not all of them are suitable
for routine genetic screening because they are either too
labour intensive and lengthy or are not capable of detecting
every kind of mutation.
Various mutations in the RB1 gene have been charac-
terised in recent years using a variety of techniques, the
simplest of which involves Southern and Northern blot
analysis. Only gross structural alterations in the gene are
detected in this way and are present in a minority (10-30%)
of Rb patients and their tumours (Blanquet et al., 1991;
Fung et al., 1987; Goddard et al., 1988; Kloss et al., 1991;
Mitchell & Cowell, 1989). Small deletions and insertions have
been detected using the RNase protection technique (Dunn et
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al., 1988; Dunn et al., 1989) which apparently detects only
50% of possible mutations. Point mutations have successfully
been detected by enzymatic amplification and direct sequenc-
ing of genomic DNA (Yandell et al., 1989). The mutations
identified so far indicated that there are no hot spots for
mutations in the RBI gene. Using these methods all 27 exons
must be screened which is very labour intensive. The single
strand conformation polymorphism (SSCP) technique, orig-
inally devised by Orita et al. (1989), has successfully detected
mutations in many genes including the cystic fibrosis gene
(Dean et al., 1990) and the p53 gene (Mazars et al., 1991).
This technique, in conjunction with PCR-sequencing, has
also proved useful in identifying RBI gene mutations in
DNA from cell lines and Rb patients (Hogg et al., 1992;
Murakami et al., 1991; Onadim et al., 1992b).
In this report we describe mutations detected using the
SSCP-PCR-sequencing technique in three Rb families. The
nature of the mutations provides insights into the mutational
mechanisms involved.
Materials and methods
Constitutional DNA from patients with a family history of
Rb were analysed exon-by-exon using SSCP. Details of the
PCR and SSCP procedures have been presented in detail
elsewhere (Hogg et al., 1992). Each PCR reaction involved 30
cycles of; denaturation at 94°C for 20s, annealing at the
appropriate temperature for 20 s and extension at 72°C for
60s. The amplified fragments were digested with the appro-
priate restriction endonucleases (Table I) to improve the
sensitivity of SSCP (Hogg et al., 1992) after which they were
checked on agarose gels for full digestion. Denatured DNA
samples were electrophoresed in nondenaturing 6% (w/v)
polyacrylamide/10% (v/v) glycerol gels. For those exons
showing band shifts in SSCP analysis direct sequencing of
the PCR products was performed. For sequencing, in each
case, one of the primers used in the PCR reaction was
biotinylated at the 5' end to allow immobilisation of single-
stranded DNA on streptavidin coated magnetic Dynabeads
(Dynal, UK) which were used to separate the DNA strands
(Hogg et al., 1992). Both single strands were sequenced using
a Sequenase kit (United States Biochemical) according to the
manufacturer's instructions.
Exons 3, 13, and 17 and their flanking intron sequences
were amplified using the primers shown in Table I. Primer
pairs 13774/13773 for exon 3 and 20877/20876 for exon 17
are internal primers used for direct sequencing. The other
pair of primers for these exons (8202/8201, exon 3; 5535/
5536, exon 17) were used when amplifying for SSCP only.
For exon 13 primer pair 5528/5529 was used in amplification
both for SSCP and sequencing.
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Table I Details ofthe oligonucleotide primers used to amplify exons 3, 13, 17 and theirflankingintron sequences ofthe RB1 gene.
The annealing temperature for PCR amplification, full size ofthe amplified fragment, restriction enzymes used to digest the PCR
products for SSCP analysis and the sizes of cut fragments are given where appropriate
Full
Oligo location Sequence (5'-3') Temp 'C size (bp) Enzyme Cut size (bp)
8202 RB 5 x 3 GCCATCAGAAGGATGTGTTACAA 58 477 AluI 243
8201 RB 3 x 3 GGACACAAACTGCTACCTCTTAAAG 234
13774 RB S x 3 TTGACCTAGATGAGATGTCGTTCACC 59 200 -
13773 RB 3 x 3 GGCAGTTCACTATTTGGTCCAAGTT
5528 RB 5 x 13 TAATAGGGTTTTTTAGTTGTACTGT 60 570 EcoRI 225
5529 RB 3 x 13 AATTTCTACAATGGCTATGTGTTCC Asel 166/179
5535 RB 5 x 17 ATAAAAATGGTTTAACCTTTCTACT 55 555 RsaI/NdeI 142/119
5536 RB 3 x 17 GTGGCATGTTTTAAGAAAAGCTATT Sau3AI 104/101/89
20877 RB 5 x 17 ACTTCCAAAAAAATACCTAGCTCAAG 58 318 -
20876 RB 3 x 17 TTTGTTAGCCATATGCACATGAATG
Results
SSCP analysis
In this study we analysed a limited number of patients with
familial Rb using SSCP and PCR sequencing. The families
studied were selected from a large series previously used in
linkage analysis (Cowell et al., 1987; Onadim & Cowell, 1991;
Onadim et al., 1990). Abnormal banding patterns were seen
on SSCP gels from the affected members of three families;
RBF58, RBF59 and RBF64, the pedigrees of which are
shown in Figure 1. In all three families, affected individuals
had bilateral, mutlifocal disease and the tumour phenotype
segregated as an autosomal dominant trait. SSCP gels from
these families are shown in Figures 2a, 3a and 4a. The SSCP
gel from RBF64 (Figure 2a) identified extra bands in the
DNA from affected individuals 11.2 and 111.1. This exon also
contains a single base pair polymorphism (Yandell & Dryja,
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Figure 1 Pedigrees for the three families used in SSCP analysis.
Figure 2 SSCP and sequence analysis of exon 3 from family
RBF64. The SSCP gel (a) contains DNA from a number of
unrelated patients, which serve as controls, all of which show the
normal band pattern (lanes 1-2 and 7- 10) as do unaffected
individuals I.2 and 11.3 from RBF64. DNA from the affected
individuals (lanes 4 and 6) exhibit extra bands compared to the
normal pattern. In (b) the DNA sequence of the non-coding
strand from II.2 is compared with a normal DNA sequence
(right) for this part of exon 3. As a result of a two base pair
deletion, the sequence ladder from the mutant allele is super-
imposed on the normal one, resulting in two bands at most
positions on the gel from the point of deletion (arrow).
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Figure 3 An SSCP gel (a) containing the digested fragments of PCR-amplified exon 13. A DNA sample from individual 1.2 from
family RBF58 (lane 11) is compared with a number of unrelated individuals which serve as controls. DNA from I.2 exhibited
additional bands (arrow) on the gel. The sequence of the coding strand (b) from 1.2 is compared with the normal sequence (right)
around the point of the insertion (arrow). As a result of the insertion, the sequence ladder of the mutant allele is superimposed on
the normal, resulting in two bands at each position on the gel.
1989), unrelated to the mutation for which II.2 is homo-
zygous and III.1 is heterozygous. Hence DNA banding pat-
terns from these individuals differ slightly although they
carry the same mutation. The SSCP gel from family RBF58
(Figure 3a) showed the extra bands observed in exon 13 after
double digests with EcoRI and Ase I whereas in RBF59,
despite the generation of many bands following restriction
enzyme treatment of exon 17, the novel band migrates closely
with the higher molecular weight band (Figure 4a).
Sequence analysis
DNA sequencing in all three exons showing abnormal SSCP
band profiles revealed mutations. A deletion was found in
exons 3 and 17 in RBF64 and RBF59 respectively and a one
base pair insertion was found in exon 13 in RBF58. Since the
mutation is heterozygous in constitutional cells from these
patients the mutant sequence is superimposed on the normal
sequence from the point of the deletion or insertion (Figures
2b, 3b, 4b). In RBF58 an additional 'A' is inserted in the
coding strand (Figure 3b), 50 bp from the 5' end of exon 13.
The 2 bp deletion in RBF64 (Figure 2b) eliminated the 106th
(A) and 107th (T) nucleotides of exon 3 from one allele. The
one bp deletion in RBF59 (Figure 4b), on the other hand,
eliminated one of the two 'A's (coding strand) present at the
131st and 132nd nucleotides of exon 17. When this analysis
was extended to DNA from the unaffected members of these
families all showed only the normal sequence for these exons.
Mechanisms ofmutation
When the nucleotide sequence around the deletions and the
insertion were examined specific motifs were identified
(Figure 5). In exon 3 (Figure Sb) an imperfect 8-9 bp direct
repeat was identified and the deleted bases lay within the
repeat elements. Alternatively, the first repeat could be
regarded as a quasi repeat (i.e. identical to the mutant
sequence) which is reproduced by the deletion. The insertion
in exon 13 also occurred within imperfect direct repeat
sequences (Figure Sa) parts of which are symmetrical to each
other. In exon 17, the situation is more complex. There are
two sequences (Figure Sc), starting 20 bp upstream and 6 bp
downstream of the deleted nucleotide, that are inverted
repeats of which parts also form dyad symmetries of each
other (T'Ang et al., 1989). On the DNA strand carrying the
single base pair deletion in exon 17, a 5-7 bp repeat is
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Figure 4 SSCP gel (a) containing enzyme digested fragments of exon 17 from four controls (1,2,4,5) and individual 1.1I from family
RBF59 (lane 3). Despite the complex banding pattern produced when compared to the other samples DNA from RBF59 shows an
extra band just below the first band at the top of the gel (arrow). In (b) the sequence of the non-coding strand of exon 17 from
DNA from 1.1 (left) is compared with the same region from normal DNA (right). As a result of the deletion of a 'T' nucleotide in
one allele from the position indicated by the arrow, the sequence carrying the deletion is superimposed on the normal sequence
from that point.
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Figure 5 Nucleotide sequences of the coding strand around the deletion/insertion areas in exon 3, 13 and 17 of the RB1 gene.
Nucleotides marked * vary between repeats. Sequences similar to the putative DNA polymerase a arrest sites are shown in italics.
(a) The nucleotide sequence of exon 13 and the amino acids it encodes around the insertion point. The point of insertion of 'A'
between the first two bases (A-TA) ofcodon number 422 is indicated with an arrow. The reading frameshift caused by the insertion
converts Ile to Asn and then leads to a stop codon further down. The 8-9 bp imperfect direct repeat sequence, within which the
extra 'A' is located, is underlined. A part of the repeat sequences is symmetrical (AGGATATAGGA). (b) The nucleotide sequence
of exon 3 (upper case) and intron 3 (lower case) flanking the deletion endpoints. The splice donor site at exon 3/intron 3 boundary
is indicated (I). The 8-9 bp imperfect direct repeat sequences are underlined and the deleted bases are enclosed in the box. The
sequence ACAGAAA also represents a quasi repeat. (c) The nucleotide sequence of exon 17 around the deletion area. The deleted
nucleotide (A) is boxed and the 5-7 bp imperfect direct repeat sequences are underlined. The boxed sequences are inverted repeats.962 Z. ONADIM et al.
present three times in tandem (Figure 5c). Sequences similar
to the putative DNA polymerase a arrest sites (Weaver &
DePamphilis, 1982) and the deletion consensus sequence (TG
A/G A/G G/T A/C) described by Krawczak and Cooper
(1991) were also observed around these mutations (sequences
shown in italics in Figure 5).
Consequences ofthe mutations
All three mutations resulted in frameshifts leading to
premature stop codons downstream. The frameshift in exon
13 starts at codon 422 and leads to the generation of a stop
codon nearby at codon 427 (Figure 5a) and this would be
expected to result in the production of a truncated protein
426 amino acids long. As a result of the 2 bp deletion in exon
3 (Figure Sb), the first two nucleotides of codon 124 (AlA)
are altered and a reading frameshift generates a premature
stop codon in exon 4, at codon 129, which would be expected
to lead to the production of a truncated protein only 128
amino acids long. The splice donor site for exon 3, however,
is only 9 bp downstream of the deleted nucleotides (Figure
5b) and it is not possible to predict whether this change in
DNA sequence would affect the use of this splice site. In
exon 17 the frameshift starts at codon 544 and leads to the
generation of a premature stop codon at codon 546 which
would be expected to result in the production of a truncated
protein 545 amino acids long.
Discussion
In an essentially random survey of patients with hereditary
Rb, we have identified three small deletions/insertions which
show a remarkable consistency in the local DNA sequence
environment where they occur. All of these mutations result
in the generation of premature stop codons which is consis-
tent with the limited number of other mutations described in
individuals with bilateral, multifocal tumours (Dunn et al.,
1989; Hogg et al., 1992; Lohmann et al., 1992; Yandell et al.,
1989). These mutations would be expected to result in the
production of non-functional proteins consistent with the
identity of RB1 as a recessive oncogene (Cowell, 1992). All
three mutations reported here are in different exons which
contributes to the emerging pattern that no particular part of
the gene is preferentially involved in mutation (Canning &
Dryja, 1989; Dunn et al., 1989; Yandell et al., 1989).
The three mutations described here are all part of short
imperfect direct repeats. The regions of the RB1 gene where
these mutations are identified also contain interspersed
repetitive DNA sequences (McGee et al., 1989), direct and
inverted repeat sequences and/or dyad symmetrical elements
(T'Ang et al., 1989). There is evidence in many genes
(Efstratiadis et al., 1980; Farabaugh et al., 1978) that short
direct repeats are involved in the generation of deletions and
insertions, including RB1 (Canning & Dryja, 1989; Dunn et
al., 1989; Hashimoto et al., 1991; Lohmann et al., 1992).
Roth et al. (1985) concluded that short direct repeats, of at
least 2 bp, occurred more frequently than would be expected
from random breakage and reunion. Krawczak and Cooper
(1991) reported the presence of 2-8 bp direct repeats in all
but one of the 60 small (<20 bp) deletions analysed at many
different genetic loci. In explanation of the presence of short
direct repeats which are deemed unlikely to support recom-
bination between chromosomes, a 'slipped mispairing' model
was put forward (Efstratiadis et al., 1980). In this model, the
repeat sequences mispair during DNA replication at the rep-
lication fork leading to the formation of a single-stranded
loop, containing one whole repeat and the sequences between
the repeats, which is then excised. Despite the prediction,
deletion of one whole copy of the repeat rarely occurs
(Krawczak & Cooper, 1991). In the two deletions we
analysed, although short imperfect direct repeats were
observed it was difficult to predict the site of deletion
accurately using the slipped mispairing model. Alternative
mechanisms involving the repeats exist, however. In exon 3,
for example, it is possible that the transient mispairing of the
two imperfect repeat units at some stage during DNA rep-
lication gives rise to the looping out and excision of the
non-homologous bases. Alternatively, the first repeat is a
quasi repeat which might have been copied producing the
deletion. Another mechanism involves short runs of the same
bases. In exon 17, for example, one of the two 'AA'
nucleotides is deleted. At this locus, transient misalignment
of the newly synthesised strand by one base pair could have
resulted in the excision of the missed, unpaired 'A'. Twenty-
seven out of 60 deletions studied by Krawczak and Cooper
(1991) contained inverted repeats which either flanked or
span the deletions. Frequent co-occurrence, as in the case of
exon 17 deletion reported here, of inverted repeats and direct
repeats at sites of deletions were also noted (Krawczak &
Cooper, 1991). That these sequences can form stem and loop
structures tends to suggest that they are potential hot spots
for structural rearrangements, possibly also generating struc-
tures recognised by eukaryotic endonucleases such as
topoisomerase I (Nalbantoglu et al., 1986). A mechanism
involving the formation of a hairpin loop was suggested by
Shew et al. (1990) in a deletion they reported in the RB1
gene.
The structural motifs we observed around the two dele-
tions were also present around the insertion in exon 13
suggesting that insertions may arise by a similar mechanism.
Not only is the insertion within 8-9 bp direct repeats, parts
of which are symmetrical, but this particular repeat sequence
is also present in exon 10, 11 and 27 of the RB1 gene (T'Ang
et al., 1989). The simplest mechanism for this insertion would
involve misalignment of the newly synthesised DNA over the
repeats and then re-alignment or the symmetrical element
flanking the insertion (AGGATAATAGGA) giving rise to
secondary structures such as Moebius loops (Cooper & Kraw-
czak, 1991) which facilitate an insertion. We have previously
reported another insertion in exon 20 of RB1 which is
associated with a 4 bp direct repeat (Hogg et al., 1992). In the
analysis of Cooper and Krawczak (1991) insertions from
various genetic loci were also found to be associated with
direct repeats and/or symmetrical elements which suggests the
involvement of these structures in insertion mutagenesis.
Deletions and insertions also appear to occur near to the
sequence TG A/G A/G G/T A/C (Cooper & Krawczak,
1991; Krawczak & Cooper, 1991) which is homologous to
the putative arrest sites for DNA polymerase a. Similar
sequences were present in all three mutations reported here
with the initial TG A being invariant. The sequence observed
near exon 13 insertion contained one mismatch in the other
three bases whereas those observed in exon 3 and 17 contained
two mismatches (Figure 5). Similar sequences exist in other
deletions and insertions in RBI (Dunn et al., 1989; Hogg et
al., 1992; Lohmann et al., 1992; Yandell et al., 1989). It has
been suggested that arrest of DNA synthesis at such sites
might, by providing a stable single stranded substrate, lead to
deletions and insertions by a variety of mechanisms (Cooper
& Krawczak, 1991; Krawczak & Cooper, 1991).
We have, thus, identified similar sequence motifs around
different mutations in the RBI gene. It will be interesting to
see whether a consistent pattern will emerge when more
mutations are characterised in this gene which might lead to
the identification of areas more likely to give rise to muta-
tions.
There have been several reports (Horowitz et al., 1990;
Mori et al., 1990; Murakami et al., 1991; Weir-Thompson et
al., 1991) where mutations in RB1 apparently result in
missense or termination codon mutations. Many of these
were from non-Rb tumours and identified because it was
possible to screen mRNA from these tumours. Although the
2 bp deletion in exon 3 in RBF64 is 9 bp upstream of the
splice donor site for exon 3 it may influence the splicing
efficiency at this site or alternatively, exon 3 might be spliced
out all together from the mature mRNA. The latter pos-
sibility, however, affects the reading frame and results in a
stop codon further down in exon 4. There is evidence from
the study of other genes that a change in the local sequenceONCOGENESIS IN FAMILIAL RETINOBLASTOMA 963
environment can affect splicing patterns (Reed & Maniatis,
1986; Steingrimsdottir et al., 1992). Because of efficient
ophthalmological screening of children born to Rb patients,
their tumours are treated in situ and so are rarely available to
study the mRNA. Whether these mutations adjacent to splice
sites affect mRNA processing will require in vitro studies.
DNA from the three families reported here were part of a
series from Rb patients and Rb tumours some of which had
distinctive phenotypes (Onadim et al., 1992b; Hogg et al.,
1993). SSCP analysis proved to be an efficient way of screen-
ing for mutations in the RBI gene. With the clinical applica-
tion of mutation screening, mutant gene carriers can be
detected in the absence of a family history. For the families
whose causative mutations have been identified, on the other
hand, unequivocal screening of unaffected individuals in the
family and the fetuses of affected individuals makes genetic
counselling straightforward.
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